ArticleCancer biology & therapy2013

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.

JianMin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.